On October 9, 2025, Novo Nordisk confirmed that FDA had given its Bloomington, Indiana plant an Official Action Indicated (OAI)
Why the Best CDMOs Track Patent Litigation Dockets and the Rest Just Track Your PO Read Post »
The FDA approved Keytruda Qlex on September 19, 2025. [12] Merck lists the US expiry year of the original Keytruda
FDA aims to act on a standard prior approval supplement in 6 months, or 10 months if the agency must
Your Second-Source Qualification Timeline Is Longer Than Your Freedom-to-Operate Window Read Post »
Glenmark launched generic Zetia in the United States on December 12, 2016. IMS Health data cited in the company’s release
On-Time Delivery Metrics Miss Day One of Generic Entry Read Post »
Eliquis has a composition-of-matter patent listed to expire on November 21, 2026 [1]. Generic apixaban cannot launch in the United
The Expiring Patent List Is Not a Business Development Strategy Read Post »
A single Excel worksheet holds 1,048,576 rows and 16,384 columns. [1] That limit is not the main problem with a
Global Patent Expiration Tracking in Excel: Where the Spreadsheet Breaks Read Post »
Novo Nordisk’s Canadian semaglutide patent, CA 2601784, lapsed because a maintenance fee went unpaid in 2019. The fee was CAD
A Patent Expiry Date Is Not a Pharma Partnership Plan Read Post »
Merck reports that the main US patent on Keytruda expires in 2028, and the same table shows 2031 for the
500 Drugs, 5 Years: What to Do With a Patent Expiry List Read Post »
Pfizer lost US exclusivity on Lipitor on November 30, 2011. [1] The EU compound patent for the same drug expired
Philippines Drug Patent Expiration: Why the US Date Is the Wrong Clock Read Post »
Sign in or create a free account to read this DrugPatentWatch article
